- Home
- CDT vs CELZ Comparison
CDT vs CELZ Comparison
Compare CDT & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- CELZ
- Stock Information
- Founded
- CDT 2019
- CELZ 1998
- Country
- CDT United States
- CELZ United States
- Employees
- CDT N/A
- CELZ N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- CDT Health Care
- CELZ Health Care
- Exchange
- CDT Nasdaq
- CELZ Nasdaq
- Market Cap
- CDT 5.2M
- CELZ 5.5M
- IPO Year
- CDT N/A
- CELZ N/A
- Fundamental
- Price
- CDT $0.54
- CELZ $1.93
- Analyst Decision
- CDT
- CELZ
- Analyst Count
- CDT 0
- CELZ 0
- Target Price
- CDT N/A
- CELZ N/A
- AVG Volume (30 Days)
- CDT 7.4M
- CELZ 100.5K
- Earning Date
- CDT 05-13-2025
- CELZ 05-09-2025
- Dividend Yield
- CDT N/A
- CELZ N/A
- EPS Growth
- CDT N/A
- CELZ N/A
- EPS
- CDT N/A
- CELZ N/A
- Revenue
- CDT N/A
- CELZ $11,000.00
- Revenue This Year
- CDT N/A
- CELZ N/A
- Revenue Next Year
- CDT N/A
- CELZ N/A
- P/E Ratio
- CDT N/A
- CELZ N/A
- Revenue Growth
- CDT N/A
- CELZ 22.22
- 52 Week Low
- CDT $0.51
- CELZ $1.69
- 52 Week High
- CDT $350.00
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- CDT 36.40
- CELZ 38.56
- Support Level
- CDT $0.52
- CELZ $1.90
- Resistance Level
- CDT $1.01
- CELZ $2.10
- Average True Range (ATR)
- CDT 0.16
- CELZ 0.24
- MACD
- CDT 0.02
- CELZ 0.06
- Stochastic Oscillator
- CDT 3.43
- CELZ 36.49
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.